Literature DB >> 33764900

Effect of restoration of euthyroidism on visfatin concentrations and body composition in women.

Nadia Sawicka-Gutaj1, Ariadna Zybek-Kocik1, Michał Kloska2, Paulina Ziółkowska1, Agata Czarnywojtek3, Jerzy Sowiński1, Dorota Mańkowska-Wierzbicka4, Marek Ruchała1.   

Abstract

Dysregulation of thyroid function has known impact on body metabolism, however, data regarding metabolic outcome after restoration of thyroid function is limited. Therefore, the aim of the study was to investigate the effect of restoration of euthyroidism on serum visfatin, and its associations with insulin resistance and body composition. This is an observational study with consecutive enrollment. Forty-nine hyperthyroid (median age of 34 years) and 44 hypothyroid women (median age of 46 years) completed the study. Laboratory parameters and body composition analysis were assessed before and after the therapy. In the hyperthyroid group, visfatin concentrations increased (P < 0.0001), while glucose concentrations decreased (P < 0.0001). Total body mass and fat mass in the trunk and limbs significantly increased during the treatment. In the hypothyroid group, significant weight loss resulted from decrease of fat and muscle masses in trunk and limbs. Visfatin serum concentrations positively correlated with total fat mass (r = 0.19, P = 0.01) and insulin concentrations (r = 0.17, P = 0.018). In conclusion, restoration of thyroid function is not associated with beneficial changes in body composition, especially among hyperthyroid females.

Entities:  

Keywords:  Graves’ disease; Hashimoto’s disease; fat tissue; nicotinamide phosphoribosyltransferase; pre-B-cell colony enhancing factor; visfatin

Year:  2021        PMID: 33764900     DOI: 10.1530/EC-21-0059

Source DB:  PubMed          Journal:  Endocr Connect        ISSN: 2049-3614            Impact factor:   3.335


  4 in total

1.  Duration of antithyroid drug treatment may predict weight gain after radioactive iodine therapy in patients with Graves' disease.

Authors:  Thewjitcharoen Yotsapon; Chatchomchuan Waralee; Prasatkaew Hussamon; Srichomchey Panita; Butadej Siriwan; Nakasatien Soontaree; Wanothayaroj Ekgaluck; Rajatanavin Rajata; Himathongkam Thep
Journal:  Heliyon       Date:  2022-05-18

2.  Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer?

Authors:  Nadia Sawicka-Gutaj; Paulina Ziółkowska; Aleksandra Derwich; Paweł Gut; Agata Czarnywojtek; Michał Kloska; Marek Ruchała
Journal:  Ther Adv Endocrinol Metab       Date:  2022-04-13       Impact factor: 4.435

Review 3.  The Role of Thyroid Hormones on Skeletal Muscle Thermogenesis.

Authors:  Nadia Sawicka-Gutaj; Abikasinee Erampamoorthy; Ariadna Zybek-Kocik; Angelos Kyriacou; Małgorzata Zgorzalewicz-Stachowiak; Agata Czarnywojtek; Marek Ruchała
Journal:  Metabolites       Date:  2022-04-07

Review 4.  Interplay between Fatty Acid Binding Protein 4, Fetuin-A, Retinol Binding Protein 4 and Thyroid Function in Metabolic Dysregulation.

Authors:  Daniela Dadej; Ewelina Szczepanek-Parulska; Marek Ruchała
Journal:  Metabolites       Date:  2022-03-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.